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ABSTRACT
Introduction: Anabolic androgenic steroids (AAS) modify the physiological functioning of the cardiovascular
system and have possible effects on the origin of cardiovascular thrombosis. Objectives: To determine the
effect of the testosterone metabolite on platelet quantification in ORX rats with or without DHT replacement.
Methods: 24 male 45-day-old wistar rats underwent orchidectomy with a simple scrotal incision. At 2.5
months of age, the 24 rats were divided into 4 study groups. Of the 12 male ORX rats, half received hormone
replacement with dihydrotestosterone propionate (DHT) at a dose of 2 mg / kg via subcutaneous injection for
7 days and the other half received physiological solution (0.9% NaCl). The same occurred in the 12 non-ORX
males (SHAM). After 7 days of administration, blood was drawn by orbital puncture and platelet quantification
was performed. Results: A significant difference (ANOVA, p < 0.005) was found between the 4 groups. When
performing the Dunn Method, a significant difference (p < 0.05) was found in the endogenous administration
of DHT between Sham rats and rats ORX + 0.9% NaCl but not with ORX + DHT. Conclusions: DHT induces an
increase in platelet quantification in Sham rats and not in ORX rats with DHT, which may affect the increase in
platelet quantification.
Key words: Androgens; Testosterone; Anabolic; Hemostasis; Platelets, DHT. (source: MeSH NLM).

RESUMEN
Introducción: Los esteroides androgénicos anabólicos (EAA) modifican el funcionamiento fisiológico del
sistema cardiovascular y tienen posibles efectos en el origen de trombosis cardiovascular. Ojetivos: Determinar
el efecto del metabolito de la testosterona en la cuantificación de plaquetas en ratas ORX con o sin reemplazo
de DHT. Métodos: 24 ratas macho wistar de 45 días de edad fueron sometidas a orquidectomía con una
incisión simple escrotal. A los 2 meses y medio de edad, las 24 ratas fueron divididas en 4 grupos de estudio.
De las 12 ratas macho ORX, la mitad recibió reemplazo hormonal con propionato de dihidrotestosterona
(DHT) a dosis de 2 mg / kg a través de una inyección subcutánea durante 7 días y la otra mitad recibió solución
fisiológica (0.9% NaCl). De la misma manera ocurrió en los 12 machos no ORX (SHAM). Después de 7 días
de administración, se extrajo sangre mediante punción orbital y se realizó la cuantificación de plaquetas.
Resultados: Se encontró una diferencia significativa (ANOVA, p < 0.005) entre los 4 grupos. Al realizar el
Método Dunn, se encontró una diferencia significativa (p < 0.05) en la administración endógena de DHT entre
ratas Sham y ratas ORX + NaCl al 0.9% pero no con ORX + DHT. Conclusión: DHT induce un aumento en la
cuantificación de plaquetas en ratas Sham y no en ratas ORX con DHT, lo que puede afectar el aumento en la
cuantificación de plaquetas.
Palabras clave: Andrógenos; Testosterona; Anabólico; Hemostasia; Plaquetas; DHT (fuente: DeCS BIREME).
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INTRODUCTION
Testosterone is the androgen derived from
cholesterol with the highest presence in men, 95%
of the total circulating testosterone (6 to 7 mg/day).
It is produced by Leydig cells in the testes(1,2).
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The main effects of testosterone are two: androgenic
and anabolic. The androgenic effects are related to
male sexual characteristics. The anabolic effects are
responsible for the formation of proteins, mainly the
increase in muscle mass(3).
A group of chemically similar steroid hormones
is anabolic-androgenic steroids (AAS)(4), which
were created to minimize androgenic effects and
maximize anabolic ones by promoting skeletal
muscle growth(5).
Among the therapeutic uses of AAS we have the
restoration of muscle mass in the treatment of
cachexia associated with severe burns, kidney
failure, and AIDS. They are also used as hormonal
substitutes in men with hypogonadism or low
levels of circulating testosterone(3,6). However, selfadministration to improve their physical conditions
is frequent in young male athletes and bodybuilders
who want to improve their physical appearance by
increasing their muscle mass(7).
Currently, studies show that the use of AAS is frequent,
and four out of five people are not athletes and use
them only for cosmetic purposes(8). Thus there is
also evidence that its use to improve performance
and acquire more muscle is increasing Worldwide.
Only in the USA at least two million people use or
have used AAS(9), on the other hand, the prevalence
in countries such as Norway, Argentina, and Poland
were 3.6%, 6.5%, and 6.2%, respectively(10-12), is older.
When the AAS are administered under medical
prescription, they do not present risks, but in athletes
who abuse androgens, these serious side effects
have been reported since 1988(13). Among those
most at risk is myocardial infarction, especially in
weightlifters(14). A stroke left ventricular hypertrophy
and sudden cardiac death are also found. Bile duct
obstruction and an increased risk of tumors have
been reported(3). All of these cases support the idea
that exogenous androgens may be thrombogenic(15).
Electrocardiographic studies show that very high
doses of AAS modify the physiological functioning
of the cardiovascular system, which is why it is
necessary to investigate the relationship between
endogenous testosterone concentration and its
https://inicib.urp.edu.pe/rfmh/vol21/iss4/8
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possible effects on the origin of cardiovascular
thrombosis(16). Testosterone therapy has also
been associated with increased expression of the
thromboxane A2 receptor on platelets, in addition to
increased platelet aggregation, potentially creating
an increased risk of thrombus formation(15).
The objective of this work was to determine the
effect of the testosterone metabolite on platelet
quantification in ORX rats with or without DHT
replacement.

METHODS
Animals
This study was carried out in male Wistar rats
weighing 200 to 300 g obtained from the Animal
Facility - Universidad Católica de Santa María.
The experimental procedures and protocols were
approved by the Ethics Committee of the Catholic
University of Santa María and are in accordance with
the IASP manual for the study of pain in animals(17).
The animals were housed in the Bioterium, in metal
cages (five rats/cage) in a room with controlled room
temperature (23 ± 1 ° C) in a 12:12 light-dark light
cycle, with food and water available ad libitum.

Orchidectomy (ORX)
45-day-old
male
Wistar
rats
underwent
orchidectomy with a simple scrotal incision. The
procedure was performed under anesthesia induced
by an intramuscular injection of ketamine (55 mg/
kg) and xylazine (5.5 mg/kg) mixture. Subcutaneous
injection of ketoprofen (5 mg/kg) was used for
postoperative analgesia(18). Orchidectomy rats
(ORX) were subjected to experimentation 4 weeks
after surgery. The sham rats operated underwent
a surgical procedure similar to that of the ORX rats,
except that the gonads were not removed(19,20).

Hormone administration
At 2 and a half months of age, the 24 rats were
divided into 4 groups of study (6 rats in each group).
The group with 12 male ORX rats, consisted of 6
animals that received hormone replacement with
dihydrotestosterone propionate (DHT) at a dose
of 2 mg/kg through a subcutaneous injection for 7
days and, and 6 animals that received physiological
solution (0.9% NaCl)(21). Another parallel group
with 12 non-ORX males was called rats SHAM
(simulated), 6 of which received daily subcutaneous
administration of DHT propionate at a dose of 2 mg/
kg and the other half physiological serum (0.9% NaCl)
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for 7 days. The systemic administration of DHT, in
ORX rats, was performed as a replacement to match
physiological levels compatible with that observed
in shams(21). To determine if DHT induces an increase

in platelet count, ORX or sham DHT (2mg/kg) and
ORX rats or sham NaCl (0.9%) were administered.

RESULTS

ORIGINAL PAPER

Figure 1. Effect of testosterone on platelet quantification. The administration of testosterone in sham rats
induced a significantly higher platelet quantification when compared to the group of sham rats with NaCl.
Symbol * (P <0.05, Student's t-test). In this figure, data are expressed as mean ± SEM of platelet quantification,
six rats per group.
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Figure 2. Effect of testosterone on platelet quantification. Testosterone administration in orchidectomized
rats induced a significantly higher platelet count when compared to the group of rats orchidectomized
with NaCl. Symbol * (P <0.05, Student's t-test). In this figure, data are expressed as mean ± SEM of platelet
quantification, six rats per group.

Figure 3. Effect of testosterone on platelet quantification. Rats orchidectomized with NaCl present lower
platelet quantification when compared with the sham group with NCl, and the sham group with testosterone.
Symbol * (P <0.001, Kruskal-Wallis). In this figure, data are expressed as mean ± SEM of platelet quantification,
six rats per group.
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One-way ANOVA was used to determine if there
were significant differences between the groups in
Figure 1, the level of statistical significance was P
<0.005. The Dunn Method post hoc test was used
to determine the basis for significant differences.
The T-test or the Rank Sum Test were used when
appropriate; the level of statistical significance was
P <0.04. Data are presented in figures as means ±
SEM. The Sigma Stat program was used for statistical
analysis.
DHT administration in male ORX rats induced a
quantification response similar to that induced
by 0.9% NaCl (saline). However, the quantification
response induced by the administration of DHT

Published by INICIB-URP, 2021
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Figure 4. Effect of testosterone on platelet quantification. Rats orchidectomized with testosterone show
lower platelet count when compared to the sham group with testosterone. Symbol * (P <0.001, Student's
t-test). In this figure, data are expressed as mean ± SEM of platelet quantification, six rats per group.
in sham males was significantly greater than that
induced by 0.9% NaCl (Figure 1), one-way ANOVA,
p <0.005, and test to compare two groups (p
<0.04). The quantification response found similar
endogenous testosterone results in ORX males and
males sham with 0.9% NaCl, which showed that the
DHT dose was physiological concentration (failed
T-test, p <0.05). The statistical difference between
endogenous DHT administration between rats
sham and ORX male rats (Dunn method, p <0.05)
suggests that the impact of the prolonged reduction
in physiological testosterone concentration,
through ORX, on platelet expression TXA2 affects
upregulation of platelets, suggesting controlled
endogenous testosterone concentration.
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Figure 5. Orchidectomization of male rats. A simple scrotal incision was made under anesthesia, the testicle
was identified, the spermatic cord was tied, and the cut was made to avoid bleeding. The same was done in
the other gonad(19).

Figure 6. Excised testicles. Both gonads are excised, with remains of the epididymis.
https://inicib.urp.edu.pe/rfmh/vol21/iss4/8
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DISCUSSION
This study shows a significant difference between
the DHT replacement group and the other
comparison groups. Blood platelet levels decrease
in situations such as ORX induced by endogenous
testosterone decrease, in addition, the blood platelet
level decreases in young ORX rats that received
physiological saline when compared to the group
of rats that received exogenous DHT. A double-blind
study by Ajayi coincides with a significant increase
in platelet aggregation, with anabolic androgenic
steroids contributing to a thrombotic state(22).

In another experiment, it was seen that the
supraphysiological administration of testosterone
inhibits fibrinolytic activity and the bleeding time
is significantly prolonged; however, the platelet
aggregation induced by ADP was unchanged(27).
Studies currently suggest that the consumption
of anabolic androgenic steroids is associated with
thromboembolism and increases its thrombotic

Published by INICIB-URP, 2021

Some studies conclude that there are more harmful
events in men who had hormone replacement
therapy or consumption of anabolic androgenic
steroids(30-33); however, there are others where they
found neutral and even beneficial effects(34,35).
Given the diversity of results, this due to different
factors such as the androgen prototype used, the
number of doses, the time of treatment, the form of
administration and the type of laboratory tests that
exist for its evaluation, is that the FDA warns of the
consequences of using this type of substance without
medical consultation or indication, approving only its
use in cases of hormone replacement treatments(36).
The misuse of anabolic androgenic steroids can
lead to dependence in a physical and psychological
context(37).

ORIGINAL PAPER

Karolczack et al., Showed that the effect of sex
steroids in vitro, where testosterone is stimulated
by collagen or arachidonate, has the power to
inhibit platelet aggregation in people in the 60-65
age group, including men and women(23), a study
that evaluates the modulation of TXA2, through the
administration of testosterone, showed that the level
of TXA2 protein synthase increases in cerebral blood
vessels(24); however, more studies are required to rule
out that there is another indirect effect causing this
action. In comparison with the study by Campelo
et al., it was obtained as a result that testosterone
inhibits platelet aggregation, indicating that it is
a nitric oxide-dependent effect. Endothelial(25). In
summary, this study suggests that the administration
of steroid anabolic androgenic did not affect platelet
regulation because, after castration, the circulating
testosterone concentration is associated with a
significant decrease in platelet receptor density
TXA2(26).

risk since they inhibit the production of a platelet
aggregation inhibitor prostacyclin, generating
hypercoagulable
states(28),
also
presenting
cardiomyopathies, hypertrophy cardiac among
others(29).

Various studies indicate a higher prevalence of
anabolic-androgenic steroids in young people aged
15-24 years by 54%(11). The population that consumes
these androgens mustn’t abuse the concentrations,
given that long-term adverse effects may occur.
Our research suggests expanding and continuing
with studies to elucidate the empirical relationship
between the use of these anabolic androgenic
steroids and the consequences on the body of this
abuse, as the number of people who use these
substances continues to increase.

CONCLUSION
This study shows that DHT increases platelets in
Wistar rats when testosterone is administered at
supraphysiological levels, suggesting a probable
TXA2 pathway. Subsequent studies hope to elucidate
this likely mechanism, using TXA2 inhibitors to better
clarify through up-regulation of platelets.
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